Sanofi Dividends Paid Growth & History (SAN)
Sanofi paid €4.77B in dividends during fiscal 2025.
View full Sanofi company overviewSanofi annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €4.77B | €68.0M | +1.45% |
| 2024 | 2024-12-31 | €4.70B | €250.0M | +5.61% |
| 2023 | 2023-12-31 | €4.45B | €286.0M | +6.86% |
| 2022 | 2022-12-31 | €4.17B | €160.0M | +3.99% |
| 2021 | 2021-12-31 | €4.01B | €71.0M | +1.80% |
| 2020 | 2020-12-31 | €3.94B | €103.0M | +2.69% |
| 2019 | 2019-12-31 | €3.83B | €61.0M | +1.62% |
| 2018 | 2018-12-31 | €3.77B | €63.0M | +1.70% |
| 2017 | 2017-12-31 | €3.71B | −€49.0M | −1.30% |
| 2016 | 2016-12-31 | €3.76B | €65.0M | +1.76% |
| 2015 | 2015-12-31 | €3.69B | — | — |
Sanofi dividends paid trends
Over the last five fiscal years, Sanofi's dividends paid increased from €3.94B to €4.77B, a change of €835.0M.
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanofi source filings ↗Community posts
Sanofi raises annual outlook as Dupixent drives double-digit sales growth
Sanofi ($SAN-EURONEXT) increased its 2026 outlook to low-teens sales growth and mid-teens growth in business earnings per share, both at constant exchange rates. Third-quarter 2026 sales reached €14.44 billion, increasing 14.3% on that basi ...